Tumor marker CA 15-3 in breast cancer patients
نویسندگان
چکیده
منابع مشابه
Tumor marker CA 15-3 in breast cancer patients.
OBJECTIVE The aim of this study was to determine whether there is a correlation between the serum concentration of the tumor marker CA 15-3 and breast cancer, which has not been proven by the existence of regional and distant metastases, and breast cancer with the presence of regional and distant metastases. PATIENTS AND METHODS The study was a retrospective-prospective study, and was conduct...
متن کاملThe relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients.
OBJECTIVE We aimed at analyzing the metastatic involvement in interpectoral (Rotter's) lymph nodes (RLN) in relation to tumor marker CA 15-3. METHODS The study included 177 female patients undergoing surgery for primary breast cancer at the University Hospital for Tumors, Zagreb, Croatia from November 2001 to March 2004. In addition to the standard surgical procedure, interpectoral RLNs were ...
متن کاملSensitivity and Specificity of CA 15-3 in Detection of Breast Cancer Recurrence
Background: The value of CA15-3(cancer antigen 15-3) marker in early detection of breast cancer recurrence has been studied in several prospective trials. But the results of these studies are different. This may be due to variable cutoff points used for analysis, different intervals between CA15-3 measurements and the differences between patients population. This study was done to examine the p...
متن کاملDiabetic type 2 and breast cancer marker CA 15 . 3 value
In this study we intended to assess the serum tumor marker CA 15.3 among diabetic females in comparison to non diabetic females without neoplasia and any other diabetic complication. Results indicate that there is statically significance between diabetic and non-diabetic females, although the levels are within the normal range of method used. It reveals that serum tumor marker CA 15.3 is useful...
متن کاملValue of CA 15-3 determination in the initial management of breast cancer patients.
CA 15-3 is the most frequently used tumour marker in invasive breast cancer. Despite poor prognosis associated with an initially high value, scientific societies have not yet recommended its determination in the initial evaluation as regards the extent of disease [1–6]. Nevertheless, some institutions, such as the Henri-Becquerel Center (HBC), routinely include CA 15-3 determination before trea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Medica Academica
سال: 2015
ISSN: 1840-1848,1840-2879
DOI: 10.5644/ama2006-124.125